GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today terminated its definitive merger agreement with STAAR Surgical Company ...
When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. In October 2024, news broke that Facebook parent company Meta had cracked an "impossible" problem ...
Broadwood Partners said it is continuing to oppose Alcon's proposed acquisition of Staar Surgical, despite the prospective buyer increasing its offer. The activist investor Broadwood, which owns 30.2% ...
Geneva, Switzerland-based eye care company Alcon has upped its bid to purchase competitor Staar Surgical, increasing its offer from $1.5 to $1.6 billion amid ongoing opposition to the deal. The new ...
Hosted on MSN
STAAR Surgical concludes go-shop period with Alcon
Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...
Broadwood Partners is attempting to call a special meeting of Staar Surgical shareholders to try to remove three Staar board directors, including the chair and chief executive. The private equity firm ...
Please provide your email address to receive an email when new articles are posted on . AI offers many benefits for practice management. When implementing AI, it is useful to think of the technology ...
In August, Geneva, Switzerland-based eye care company Alcon agreed to buy Staar Surgical in a deal valued at $1.5 billion, but STAAR has faced opposition to the deal, including from its largest ...
Oct 15 (Reuters) - Proxy advisory firm Institutional Shareholder Services on Wednesday recommended that investors in Staar Surgical (STAA.O), opens new tab reject an offer by Swiss eyecare giant Alcon ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results